2026 NPPES data Hematology & Oncology Physician NPI 1851386460 MD
Verify on CMS →

NAFISA BURHANI, MD

Hematology & Oncology Physician in JOLIET, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
582
Medicare Part D claims · 168 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.2K
52 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NAFISA BURHANI, MD filed 582 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in JOLIET, Illinois, prescribing 75% generic.

582
Part D claims, 2023
75%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NAFISA BURHANI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

582 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

NAFISA BURHANI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NAFISA BURHANI, MD?

Quality data not reported

NPI registry status

Active

Issued 09/20/2005

NPI 1851386460

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

582 31% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Illinois

How Hematology & Oncology Physician compares to other specialties among Illinois providers

Illinois providers

Hematology & Oncology Physician share within Illinois

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAFISA BURHANI, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 2614 W JEFFERSON ST, JOLIET, IL, 60435, with a listed phone of (815) 725-1355. NPI 1851386460 was issued on 09/20/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BURHANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 582 prescription claims written by this provider, covering 168 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 5.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2614 W JEFFERSON ST
JOLIET, IL 60435

Provider Details

NPI 1851386460
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 09/20/2005

Hospital and facility affiliations

Facilities where NAFISA BURHANI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DUPAGE MEDICAL GROUP LTD
TINLEY PARK, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAFISA BURHANI, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to NAFISA BURHANI, MD. To verify NAFISA BURHANI, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NAFISA BURHANI, MD — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 582 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

582
Total Claims
$1.2M
Total Drug Cost
168
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
999
Total Day Supply
27,320
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$86K
Opioid Claims
29 (5.0% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.75
Gender Split
65% female / 35% male
Age Distribution
<65: 16, 65-74: 74, 75-84: 61, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NAFISA BURHANI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
73
Eliquis
Apixaban
50
Warfarin Sodium
47
Anastrozole
45
Dexamethasone
35
Acyclovir
28
Potassium Chloride
22
Prochlorperazine Maleate
21
Ibrance
Palbociclib
18
Xarelto
Rivaroxaban
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NAFISA BURHANI, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NAFISA BURHANI, MD's 582 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as BURHANI.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAFISA BURHANI, MD's specialty?
NAFISA BURHANI, MD specializes in Hematology & Oncology Physician and practices in JOLIET, Illinois. Credentials: MD.
How much does NAFISA BURHANI, MD prescribe under Medicare Part D?
In 2023, NAFISA BURHANI, MD wrote 582 Medicare Part D claims totaling $1.2M in drug costs for 168 beneficiaries.
Where is NAFISA BURHANI, MD located?
NAFISA BURHANI, MD is located at 2614 W JEFFERSON ST, JOLIET, IL, 60435. Phone: (815) 725-1355.
What is NAFISA BURHANI, MD's NPI number?
NAFISA BURHANI, MD's National Provider Identifier (NPI) is 1851386460, issued on 09/20/2005.
Does NAFISA BURHANI, MD prescribe more brand-name or generic drugs?
NAFISA BURHANI, MD's prescribing is 25% brand-name and 75% generic drugs by claim count, with $1.1M in brand drug costs.
Does NAFISA BURHANI, MD prescribe opioids?
Yes, NAFISA BURHANI, MD had 29 opioid claims in 2023 with an opioid prescribing rate of 5.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NAFISA BURHANI, MD prescribe most often?
Based on 2023 Medicare Part D data, NAFISA BURHANI, MD's most frequently prescribed drugs include Letrozole, Eliquis, Warfarin Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAFISA BURHANI, MD accept Medicare?
NAFISA BURHANI, MD appears in CMS Medicare data with 582 Part D claims and 168 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAFISA BURHANI, MD's credentials?
NAFISA BURHANI, MD's NPI is 1851386460 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology